Improvement of interpretation in cystic fibrosis clinical laboratory reports: Longitudinal analysis of external quality assessment data

European Journal of Human Genetics

Volumn 20, Issue 12, 2012, Pages 1209-1215

  Berwouts, Sarah ^a   Girodon, Emmanuelle ^b   Schwarz, Martin ^c   Stuhrmann, Manfred ^d   Morris, Michael A ^e   Dequeker, Elisabeth ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b HENRI MONDOR HOSPITAL   (France)

^c ST MARY S HOSPITAL   (United Kingdom)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e University Hospital   (Switzerland)

Author keywords

clinical interpretation; cystic fibrosis; external quality assessment; laboratory report; quality improvement

Indexed keywords

ACCREDITATION; ADULT; ARTICLE; CERTIFICATION; CLINICAL ASSESSMENT TOOL; CLINICAL LABORATORY; CYSTIC FIBROSIS; EXTERNAL QUALITY ASSESSMENT; FEMALE; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; LABORATORY TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATIENT CARE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QUALITY CONTROL;

ACCREDITATION; CASE-CONTROL STUDIES; CERTIFICATION; CLINICAL LABORATORY TECHNIQUES; CYSTIC FIBROSIS; DATA INTERPRETATION, STATISTICAL; FEMALE; GENETIC TESTING; HUMANS; LONGITUDINAL STUDIES; MEDICAL RECORDS; PREGNANCY; PRENATAL DIAGNOSIS; QUALITY ASSURANCE, HEALTH CARE;

EID: 84869219765     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.131     Document Type: Article

References (26)

1. Stenhouse SA, Middleton-Price H: Quality assurance in molecular diagnosis: the UK experience. Methods Mol Med 1996; 5: 341-352.
2. Organisation for Economic Co-operation and Development: OECD guidelines for quality assurance in molecular genetic testing 2007.
3. International Organization for Standardization: ISO 15189:2007 Medical laboratories-Particular requirements for quality and competence 2007.
4. International Organization for Standardization: ISO/IEC 17025:2005 General requirements for the competence of testing and calibration laboratories 2005.
5. Clinical Laboratory Improvement Amendments (CLIA): http://wwwn.cdc.gov/ clia/regs/toc.aspx, 2011.
6. Cystic Fibrosis European Network. http://cf.eqascheme.org/, 2011.
7. Touitou I, Rittore C, Philibert L et al: An international external quality assessment for molecular diagnosis of hereditary recurrent fevers: a 3-year scheme demonstrates the need for improvement. Eur J Hum Genet 2009; 17: 890-896.
8. Seneca S, Morris MA, Patton S et al: Experience and outcome of 3 years of a European EQA scheme for genetic testing of the spinocerebellar ataxias. Eur J Hum Genet 2008; 16: 913-920.
9. Mueller CR, Kristoffersson U, Stoppa-Lyonnet D: External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years. Ann Oncol 2004; 15(Suppl 1): I14-I17. (Pubitemid 39199326)
10. McGovern MM, Elles R, Beretta I et al: Report of an international survey of molecular genetic testing laboratories. Community Genet 2007; 10: 123-131. (Pubitemid 46944287)
11. Ramsden SC, Deans Z, Robinson DO et al: Monitoring standards for molecular genetic testing in the United Kingdom, the Netherlands, and Ireland. Genet Test 2006; 10: 147-156. (Pubitemid 44849882)
12. Qiu J, Hutter P, Rahner N et al: The educational role of external quality assessment in genetic testing: a 7-year experience of the European Molecular Genetics Quality Network (EMQN) in Lynch syndrome. Hum Mutat 2011; 32: 696-697.
13. Technical Standards and Guidelines for CFTR. Mutation Testing: http://www.acmg.net/Pages/ACMG-Activities/stds-2002/cf.htm, 2011.
14. Castellani C, Cuppens H, Macek Jr. M et al: Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 2008; 7: 179-196.
15. Dequeker E, Stuhrmann M, Morris MA et al: Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders-updated European recommendations. Eur J Hum Genet 2009; 17: 51-65.
16. Schwarz M, Gardner A, Jenkins L, Norbury G, Renwick P, Robinson D: Testing Guidelines for Molecular Diagnosis of Cystic Fibrosis. United Kingdom: Clinical Molecular Genetics Society, 2009.
17. Orphanet. http://www.orpha.net/, 2011.
18. Cassiman JJ: Research network: EuroGentest-a European Network of Excellence aimed at harmonizing genetic testing services. Eur J Hum Genet 2005; 13: 1103-1105.
19. Berwouts S, Fanning K, Morris MA, Barton DE, Dequeker E: Quality assurance practices in Europe: a survey of molecular genetic testing laboratories. Eur J Hum Genet 2012; e-pub ahead of print 20 June 2012; doi:10.1038/ejhg.2012.125.
20. UKNEQAS. http://www.ukneqas-molgen.org.uk/ukneqas/index/news.html, 2011.
21. Salvatore M, Falbo V, Floridia G et al: The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4 years of activity. Clin Chem Lab Med 2007; 45: 254-260. (Pubitemid 46294700)
22. INSTAND e.V. http://www.instandev.de/en/eqas/programm/, 2011.
23. Agence Francaise de Securite Sanitaire des Produits de Sante (afssaps). http://www.afssaps.fr/Activites/Controle-national-de-qualite-des-analyses-de- biologie-medicale-CNQ, 2011.
24. La loi Hôpital, Patients, Santé et Territoires (HPST). http://www.sante.gouv.fr/la-loihopital-patients-sante-et-territoires.html, 2011.
25. Office fédéral de la santé publique (OFSP). http://www.bag.admin.ch/themen/medizin/00683/02724/03677/11167/index.html?lang= fr, 2011.
26. Chen B, Gagnon M, Shahangian S et al: Good laboratory practices for molecular genetic testing for heritable diseases and conditions. MMWR Recomm Rep 2009; 58: 1-37.